BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 16999042)

  • 1. [Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].
    Anglaret X
    Med Trop (Mars); 2006 Aug; 66(4):343-5. PubMed ID: 16999042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
    Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
    Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
    Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
    HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries.
    Zachariah R; Massaquoi M
    Trop Doct; 2006 Apr; 36(2):79-82. PubMed ID: 16611438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of opportunistic infections in HIV-infected adults in sub-Saharan Africa: opportunities and obstacles.
    Bortolotti V; Buvé A
    AIDS; 2002 Jul; 16(10):1309-17. PubMed ID: 12131207
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
    Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
    Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of neglected tropical diseases: integrated chemotherapy and beyond.
    Utzinger J; de Savigny D
    PLoS Med; 2006 Jan; 3(5):e112. PubMed ID: 16435910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE; Reid CA; Vermund SH
    Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa.
    Harries AD; Hargreaves NJ; Kumwenda J; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):998-1001. PubMed ID: 11092710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malaria and HIV infection in subSaharan Africa: another match made in hell?].
    Aoussi EF; Tanon KA; Ehui E; Ouattara SI; Inwoley KA; Adoubryn KD; Eholié SP; Bissagnéné E
    Sante; 2011; 21(3):174-7. PubMed ID: 22294253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Providing HIV care for tuberculosis patients in sub-Saharan Africa.
    Harries AD; Boxshall M; Phiri S; van Gorkom J; Zachariah R; Squire SB; Makombe SD; Kwanjana J; Gondwett M
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1306-11. PubMed ID: 17167945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents.
    Uneke CJ; Ogbonna A
    Trans R Soc Trop Med Hyg; 2009 Aug; 103(8):761-7. PubMed ID: 18707747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi.
    Zachariah R; Harries AD; Arendt V; Wennig R; Schneider S; Spielmann M; Panarotto E; Gomani P; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):843-6. PubMed ID: 11573896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.